Viewing nowRosuvastatin Calcium 10mg Tablet
Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
KMS Pharmaceutical Co., Ltd.

MFDS item code 201508189 · Approved 2015.12.09 · Insurance code 654701630
Treatment of dyslipidemia; prevention of cardiovascular disease; inhibition of the progression of atherosclerosis
This medication is used as an adjunct to diet for the treatment of patients with primary hypercholesterolemia and mixed dyslipidemia who are not adequately controlled with diet and exercise. It is also prescribed as an adjunct to diet in patients with homozygous familial hypercholesterolemia. In patients with hypercholesterolemia, it helps lower total cholesterol and LDL cholesterol levels to target levels, delaying the progression of atherosclerosis. In children, it is used as an adjunct to diet therapy for patients with heterozygous familial hypercholesterolemia that meet specific criteria to reduce cholesterol and apolipoprotein B levels. Additionally, it assists in diet management for patients with primary dysbetalipoproteinemia and has been shown to reduce the risk of stroke, myocardial infarction, and revascularization procedures in high-risk patients with cardiovascular disease. Therefore, this medication is used for various forms of hypercholesterolemia and reduction of cardiovascular disease risk associated with dyslipidemia.
1. Primary hypercholesterolemia (type IIa, including heterozygous familial hypercholesterolemia), mixed dyslipidemia (type IIb), primary dysbetalipoproteinemia (type III), and homozygous familial hypercholesterolemia Patients should follow a standard cholesterol-lowering diet before and during treatment with this drug and continue it throughout the treatment period. This drug may be taken at any time of day, with or without food. The initial dose is 5 mg once daily; the dose may be adjusted to a maintenance dose if a greater reduction in LDL cholesterol is needed. The maintenance dose is 10 mg once daily, and most patients are controlled at this dose. The maintenance dose should be adjusted as appropriate at intervals of 4 weeks or longer according to LDL cholesterol levels, treatment goals, and the patient's response; the dose may be increased to a maximum of 20 mg once daily. 3. Older adults: No dose adjustment is necessary. 4. Patients with renal impairment: No dose adjustment is necessary in patients with mild or moderate renal impairment. Do not administer to patients with severe renal impairment. Exercise particular caution when administering 20 mg of this drug to patients with moderate renal impairment. 5. Patients with hepatic impairment: No increase in systemic exposure to rosuvastatin was observed in patients with a Child-Pugh score of 7 or less, but an increase was observed in patients with a Child-Pugh score of 8 or 9. Renal function testing should be considered in these patients. There is no experience with administration to patients with a Child-Pugh score greater than 9. Do not administer this drug to patients with active liver disease. 6. Race: Because systemic exposure to this drug is increased in Asian patients, the recommended initial dose is 5 mg. Administration of the 40 mg dose is contraindicated. 7. Patients predisposed to myopathy: The recommended initial dose for patients predisposed to myopathy is 5 mg. Administration of the 40 mg dose is contraindicated in some of these patients.
Ages 10 to 17 years: The usual dosage range is 5 mg to 20 mg once daily. (There are no clinical data on doses higher than 20 mg in the pediatric population.) The dose should be adjusted individually according to the recommended treatment goal for each patient. The dose should be adjusted at intervals of 4 weeks or longer. Under 10 years of age: Safety and efficacy have not been established.
This medication should not be used in certain patients. For example, patients who are allergic to any component of this medication, those with severe liver dysfunction, patients with muscle diseases, patients taking specific medications, those with severe kidney impairment, women who are pregnant or breastfeeding, and women of childbearing age who do not use adequate contraception should not be administered this medication. Additionally, patients at high risk for muscle disease should avoid high doses of this medication, and those with certain genetic issues like lactose intolerance should not be administered this medication. During treatment, liver function and muscle status should be regularly monitored, and caution should be exercised in patients who consume excessive alcohol or have a history of liver disease. If symptoms such as muscle pain or weakness occur, patients should promptly inform their healthcare provider, and the medication may need to be discontinued. This medication can affect the liver and muscles; therefore, it is important to monitor liver and muscle enzyme levels before and during treatment with blood tests. Furthermore, this medication may interact with several other drugs, so patients should inform their healthcare provider of any other medications they are taking. In particular, the risk of muscle side effects may increase when taken with certain antiviral medications, immunosuppressants, or fibrate-class drugs. Pregnant or breastfeeding women should not take this medication, and women of childbearing potential should use effective contraception. In cases of overdose, there is no specific antidote available, so symptomatic treatment and monitoring of liver and muscle function are necessary. Lastly, dizziness may occur while taking this medication, so caution is advised when driving or operating machinery. Patients should immediately consult their healthcare provider if any unusual symptoms arise during treatment, and it is vital to undertake regular check-ups to ensure safe treatment.
Hypersensitivity reactions including angioedema, diabetes, headache, dizziness, constipation, nausea, abdominal pain, pancreatitis, itching, rash, hives, myalgia, myopathy, rhabdomyolysis, asthenia, polyneuropathy, amnesia, peripheral neuropathy, myasthenia gravis, cough, dyspnea, diarrhea, oculomotor weakness, thrombocytopenia, jaundice, hepatitis, increased transaminases, Stevens-Johnson syndrome, eosinophilia and systemic symptom drug reaction syndrome, lichenoid drug rash, lupus-like syndrome, muscle rupture, arthralgia, immune-mediated necrotizing myopathy, hematuria, edema, depression, sleep disturbances, interstitial lung disease, sexual dysfunction, gynecomastia, fatal and non-fatal liver failure, cognitive impairment, increased ALT, chest pain, muscle cramps, gout, erectile dysfunction, increased AST, numbness, sensory abnormalities, chest discomfort, appetite loss, abdominal distension, syncope, generalized pain, fatigue
Not everyone experiences these, and they can vary from person to person.
This medication must be stored in a tightly sealed container to prevent exposure to air or moisture. It is recommended to maintain the storage temperature between 1°C and 30°C.
Pink round film-coated tablet
30 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowRosuvastatin Calcium 10.4mg
Tablet · Prescription medication
KMS Pharmaceutical Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 5.2mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Chong Kun Dang Pharmaceutical Corp.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Dong Gu Bio Pharmaceutical Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Boryung Pharmaceutical Co., Ltd.

Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication
Jongkundang Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.